# Phase IIT Trial of SNA014

> **NCT06646783** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **SmartNuclide Biopharma** · enrollment: 28 (estimated)

## Conditions studied

- Adenocarcinoma of the Stomach
- Adenocarcinoma of GE Junction
- Pancreatic Cancer Stage

## Interventions

- **DRUG:** [68Ga]Ga-NODAGA-SNA014

## Key facts

- **NCT ID:** NCT06646783
- **Lead sponsor:** SmartNuclide Biopharma
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-10-20
- **Primary completion:** 2025-10-20
- **Final completion:** 2025-11-20
- **Target enrollment:** 28 (ESTIMATED)
- **Last updated:** 2024-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06646783

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06646783, "Phase IIT Trial of SNA014". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06646783. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*